U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H19NO
Molecular Weight 265.3496
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of DESMETHYLDOXEPIN, (E)-

SMILES

CNCC\C=C1\C2=CC=CC=C2OCC3=C1C=CC=C3

InChI

InChIKey=HVKCEFHNSNZIHO-MHWRWJLKSA-N
InChI=1S/C18H19NO/c1-19-12-6-10-16-15-8-3-2-7-14(15)13-20-18-11-5-4-9-17(16)18/h2-5,7-11,19H,6,12-13H2,1H3/b16-10+

HIDE SMILES / InChI

Molecular Formula C18H19NO
Molecular Weight 265.3496
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Z-N-desmethyldoxepin is an active metabolite of doxepin, a tricyclic antidepressant. Z-N-desmethyldoxepin appeared to be a terminal oxidative metabolite, in comparison with isomeric form E-N-desmethyl-doxepin, which is undergone further oxidation under the action of CYP2D6 activity.

Originator

Curator's Comment: College of Pharmacy, University of Saskatchewan

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Geometric isomerization of doxepin during its N-demethylation in humans.
1991 May-Jun
Determination of doxepin and desmethyldoxepin in human plasma using liquid chromatography-tandem mass spectrometry.
2000 May 26
Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin.
2000 Oct
Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteers.
2002 Oct
[Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].
2006 Jun
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In 'metabolic consumption' experiments with liver microsomes (having measurable CYP2D6 activity) and initial substrate concentration of 1 microM, the consumption of E-doxepin was greater than that of Z-doxepin. With N-desmethyldoxepin, quinidine inhibited the consumption of E-N-desmethyl-doxepin whereas Z-N-desmethyldoxepin appeared to be a terminal oxidative metabolite. CYP2D6 is a major oxidative enzyme in doxepin metabolism; predominantly catalysing hydroxylation with an exclusive preference for the E-isomers. The relatively more rapid metabolism of E-isomeric forms, and the limited metabolic pathways for the Z-isomers explained the apparent enrichment of Z-N-desmethyldoxepin.
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:17:36 UTC 2023
Edited
by admin
on Fri Dec 15 18:17:36 UTC 2023
Record UNII
J7JTC0A5D6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DESMETHYLDOXEPIN, (E)-
Common Name English
TRANS-DESMETHYLDOXEPIN
Common Name English
1-PROPANAMINE, 3-DIBENZ(B,E)OXEPIN-11(6H)-YLIDENE-N-METHYL-, (3E)-
Systematic Name English
(E)-3-(DIBENZO(B,E)OXEPIN-11(6H)-YLIDENE)-N-METHYLPROPAN-1-AMINE
Systematic Name English
DOXEPIN HYDROCHLORIDE IMPURITY C [EP IMPURITY]
Common Name English
DOXEPIN IMPURITY C
Common Name English
(E)-DESMETHYLDOXEPIN
Common Name English
1-PROPANAMINE, 3-DIBENZ(B,E)OXEPIN-11(6H)-YLIDENE-N-METHYL-, (E)-
Systematic Name English
Code System Code Type Description
PUBCHEM
6433351
Created by admin on Fri Dec 15 18:17:37 UTC 2023 , Edited by admin on Fri Dec 15 18:17:37 UTC 2023
PRIMARY
FDA UNII
J7JTC0A5D6
Created by admin on Fri Dec 15 18:17:37 UTC 2023 , Edited by admin on Fri Dec 15 18:17:37 UTC 2023
PRIMARY
EPA CompTox
DTXSID60217319
Created by admin on Fri Dec 15 18:17:37 UTC 2023 , Edited by admin on Fri Dec 15 18:17:37 UTC 2023
PRIMARY
CAS
67035-76-1
Created by admin on Fri Dec 15 18:17:37 UTC 2023 , Edited by admin on Fri Dec 15 18:17:37 UTC 2023
PRIMARY
CHEBI
142340
Created by admin on Fri Dec 15 18:17:37 UTC 2023 , Edited by admin on Fri Dec 15 18:17:37 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP